New dog and new tricks: Evolving roles for IL-33 in type 2 immunity

Journal of Leukocyte Biology

Volumn 97, Issue 6, 2015, Pages 1037-1048

  Lott, Jeremy M ^a,b   Sumpter, Tina L ^b   Turnquist, Hēth R ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Fibrosis; Immune response; Innate immune cells; ST2; T helper cells

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; PROTEIN; ST2 PROTEIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; IL1RL1 PROTEIN, HUMAN; IL33 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; STAT PROTEIN;

ADAPTIVE IMMUNITY; ATOPY; BASOPHIL; CD4+ T LYMPHOCYTE; CYTOKINE RELEASE; DENDRITIC CELL; EOSINOPHIL; HUMAN; IMMUNE RESPONSE; IMMUNITY; INFLAMMATION; INNATE IMMUNITY; LYMPHOID CELL; MACROPHAGE; MAST CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TH2 CELL; TISSUE REPAIR; TYPE 2 IMMUNITY; WOUND HEALING; ANIMAL; EPITHELIUM CELL; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; GRANULOCYTE; IMMUNOLOGY; PATHOLOGY;

CANIS FAMILIARIS;

ADAPTIVE IMMUNITY; ANIMALS; DENDRITIC CELLS; EPITHELIAL CELLS; FIBROSIS; GENE EXPRESSION REGULATION; GRANULOCYTES; HUMANS; INFLAMMATION; INTERLEUKINS; MACROPHAGES; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TH2 CELLS;

EID: 84930260934     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3RI1214-595R     Document Type: Review

References (165)

1. Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., Gorman, D. M., Bazan, J. F., Kastelein, R. A. (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479–490.
2. Tominaga, S. (1989) A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Lett. 258, 301–304.
3. Yanagisawa, K., Takagi, T., Tsukamoto, T., Tetsuka, T., Tominaga, S. (1993) Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. FEBS Lett. 318, 83–87.
4. Löhning, M., Stroehmann, A., Coyle, A. J., Grogan, J. L., Lin, S., Gutierrez-Ramos, J.-C., Levinson, D., Radbruch, A., Kamradt, T. (1998) T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc. Natl. Acad. Sci. USA 95, 6930–6935.
5. Xu, D., Chan, W. L., Leung, B. P., Huang, Fp., Wheeler, R., Piedrafita, D., Robinson, J. H., Liew, F. Y. (1998) Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J. Exp. Med. 187, 787–794.
6. Lanzavecchia, A., Sallusto, F. (2001) Regulation of T cell immunity by dendritic cells. Cell 106, 263–266.
7. Zhu, J., Paul, W. E. (2008) CD4 T cells: fates, functions, and faults. Blood 112, 1557–1569.
8. Howard, M., Farrar, J., Hilfiker, M., Johnson, B., Takatsu, K., Hamaoka, T., Paul, W. E. (1982) Identification of a T cell-derived b cell growth factor distinct from interleukin 2. J. Exp. Med. 155, 914–923.
9. Finkelman, F. D., Katona, I. M., Urban, Jr., J. F., Holmes, J., Ohara, J., Tung, A. S., Sample, J. V., Paul, W. E. (1988) IL-4 is required to generate and sustain in vivo IgE responses. J. Immunol. 141, 2335–2341.
10. Barnes, P. J. (2008) Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol. 8, 183–192.
11. Hamid, Q., Tulic, M. (2009) Immunobiology of asthma. Annu. Rev. Physiol. 71, 489–507.
12. Zhao, P., Xiao, X., Ghobrial, R. M., Li, X. C. (2013) IL-9 and Th9 cells: progress and challenges. Int. Immunol. 25, 547–551.
13. Wynn, T. A. (2003) IL-13 effector functions. Annu. Rev. Immunol. 21, 425–456.
14. Borthwick, L. A., Wynn, T. A., Fisher, A. J. (2013) Cytokine mediated tissue fibrosis. Biochim. Biophys. Acta 1832, 1049–1060.
15. Hancock, A., Armstrong, L., Gama, R., Millar, A. (1998) Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung. Am. J. Respir. Cell Mol. Biol. 18, 60–65.
16. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23–35.
17. Gross, A., Ben-Sasson, S. Z., Paul, W. E. (1993) Anti-IL-4 diminishes in vivo priming for antigen-specific IL-4 production by T cells. J. Immunol. 150, 2112–2120.
18. Snapper, C. M., Finkelman, F. D., Paul, W. E. (1988) Differential regulation of IgG1 and IgE synthesis by interleukin 4. J. Exp. Med. 167, 183–196.
19. Kuperman, D. A., Huang, X., Koth, L. L., Chang, G. H., Dolganov, G. M., Zhu, Z., Elias, J. A., Sheppard, D., Erle, D. J. (2002) Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat. Med. 8, 885–889.
20. Whittaker, L., Niu, N., Temann, U.-A., Stoddard, A., Flavell, R. A., Ray, A., Homer, R. J., Cohn, L. (2002) Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9. Am. J. Respir. Cell Mol. Biol. 27, 593–602.
21. Liu, Q., Turnquist, H. R. (2013) Implications for interleukin-33 in solid organ transplantation. Cytokine 62, 183–194.
22. Moussion, C., Ortega, N., Girard, J.-P. (2008) The IL-1-like cytokine IL- 33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘alarmin’? PLoS ONE 3, e3331.
23. Pichery, M., Mirey, E., Mercier, P., Lefrancais, E., Dujardin, A., Ortega, N., Girard, J.-P. (2012) Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J. Immunol. 188, 3488–3495.
24. Küchler, A. M., Pollheimer, J., Balogh, J., Sponheim, J., Manley, L., Sorensen, D. R., De Angelis, P. M., Scott, H., Haraldsen, G. (2008) Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation. Am. J. Pathol. 173, 1229–1242.
25. Seki, K., Sanada, S., Kudinova, A. Y., Steinhauser, M. L., Handa, V., Gannon, J., Lee, R. T. (2009) Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling. Circ Heart Fail 2, 684–691.
26. Yagami, A., Orihara, K., Morita, H., Futamura, K., Hashimoto, N., Matsumoto, K., Saito, H., Matsuda, A. (2010) IL-33 mediates inflammatory responses in human lung tissue cells. J. Immunol. 185, 5743–5750.
27. Sakai, N., Van Sweringen, H. L., Quillin, R. C., Schuster, R., Blanchard, J., Burns, J. M., Tevar, A. D., Edwards, M. J., Lentsch, A. B. (2012) Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice. Hepatology 56, 1468–1478.
28. Bonilla, W. V., Fröhlich, A., Senn, K., Kallert, S., Fernandez, M., Johnson, S., Kreutzfeldt, M., Hegazy, A. N., Schrick, C., Fallon, P. G., Klemenz, R., Nakae, S., Adler, H., Merkler, D., Löhning, M., Pinschewer, D. D. (2012) The alarmin interleukin-33 drives protective antiviral CD8⁺ T cell responses. Science 335, 984–989.
29. Talabot-Ayer, D., Lamacchia, C., Gabay, C., Palmer, G. (2009) Interleukin-33 is biologically active independently of caspase-1 cleavage. J. Biol. Chem. 284, 19420–19426.
30. Zhao, W. H., Hu, Z. Q. (2012) Up-regulation of IL-33 expression in various types of murine cells by IL-3 and IL-4. Cytokine 58, 267–273.
31. Xu, D., Jiang, H.-R., Kewin, P., Li, Y., Mu, R., Fraser, A. R., Pitman, N., Kurowska-Stolarska, M., McKenzie, A. N. J., McInnes, I. B., Liew, F. Y. (2008) IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc. Natl. Acad. Sci. USA 105, 10913–10918.
32. Polumuri, S. K., Jayakar, G. G., Shirey, K. A., Roberts, Z. J., Perkins, D. J., Pitha, P. M., Vogel, S. N. (2012) Transcriptional regulation of murine IL-33 by TLR and non-TLR agonists. J. Immunol. 189, 50–60.
33. Hsu, C.-L., Neilsen, C. V., Bryce, P. J. (2010) IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS ONE 5, e11944.
34. Anthony, R. M., Kobayashi, T., Wermeling, F., Ravetch, J. V. (2011) Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway. Nature 475, 110–113.
35. Tjota, M. Y., Williams, J. W., Lu, T., Clay, B. S., Byrd, T., Hrusch, C. L., Decker, D. C., de Araujo, C. A., Bryce, P. J., Sperling, A. I. (2013) IL-33- dependent induction of allergic lung inflammation by FcgRIII signaling. J. Clin. Invest. 123, 2287–2297.
36. Sanada, S., Hakuno, D., Higgins, L. J., Schreiter, E. R., McKenzie, A. N., Lee, R. T. (2007) IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J. Clin. Invest. 117, 1538–1549.
37. Kakkar, R., Hei, H., Dobner, S., Lee, R. T. (2012) Interleukin 33 as a mechanically responsive cytokine secreted by living cells. J. Biol. Chem. 287, 6941–6948.
38. Rickard, J. A., O’Donnell, J. A., Evans, J. M., Lalaoui, N., Poh, A. R., Rogers, T., Vince, J. E., Lawlor, K. E., Ninnis, R. L., Anderton, H., Hall, C., Spall, S. K., Phesse, T. J., Abud, H. E., Cengia, L. H., Corbin, J., Mifsud, S., Di Rago, L., Metcalf, D., Ernst, M., Dewson, G., Roberts, A. W., Alexander, W. S., Murphy, J. M., Ekert, P. G., Masters, S. L., Vaux, D. L., Croker, B. A., Gerlic, M., Silke, J. (2014) RIPK1 regulates RIPK3- MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 157, 1175–1188.
39. Cayrol, C., Girard, J.-P. (2009) The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc. Natl. Acad. Sci. USA 106, 9021–9026.
40. Haraldsen, G., Balogh, J., Pollheimer, J., Sponheim, J., Küchler, A. M. (2009) Interleukin-33—cytokine of dual function or novel alarmin? Trends Immunol. 30, 227–233.
41. Oboki, K., Ohno, T., Kajiwara, N., Arae, K., Morita, H., Ishii, A., Nambu, A., Abe, T., Kiyonari, H., Matsumoto, K., Sudo, K., Okumura, K., Saito, H., Nakae, S. (2010) IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc. Natl. Acad. Sci. USA 107, 18581–18586.
42. Chan, J. K., Roth, J., Oppenheim, J. J., Tracey, K. J., Vogl, T., Feldmann, M., Horwood, N., Nanchahal, J. (2012) Alarmins: awaiting a clinical response. J. Clin. Invest. 122, 2711–2719.
43. Townsend, M. J., Fallon, P. G., Matthews, D. J., Jolin, H. E., McKenzie, A. N. (2000) T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J. Exp. Med. 191, 1069–1076.
44. Coyle, A. J., Lloyd, C., Tian, J., Nguyen, T., Erikkson, C., Wang, L., Ottoson, P., Persson, P., Delaney, T., Lehar, S., Lin, S., Poisson, L., Meisel, C., Kamradt, T., Bjerke, T., Levinson, D., Gutierrez-Ramos, J. C. (1999) Crucial role of the interleukin 1 receptor family member T1/ ST2 in T helper cell type 2-mediated lung mucosal immune responses. J. Exp. Med. 190, 895–902.
45. Yang, Q., Li, G., Zhu, Y., Liu, L., Chen, E., Turnquist, H., Zhang, X., Finn, O. J., Chen, X., Lu, B. (2011) IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells. Eur. J. Immunol. 41, 3351–3360.
46. Komai-Koma, M., Gilchrist, D. S., McKenzie, A. N., Goodyear, C. S., Xu, D., Liew, F. Y. (2011) IL-33 activates B1 cells and exacerbates contact sensitivity. J. Immunol. 186, 2584–2591.
47. Komai-Koma, M., Brombacher, F., Pushparaj, P. N., Arendse, B., McSharry, C., Alexander, J., Chaudhuri, R., Thomson, N. C., McKenzie, A. N. J., McInnes, I., Liew, F. Y., Xu, D. (2012) Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in na¨ıve mice. Allergy 67, 1118–1126.
48. Sattler, S., Ling, G.-S., Xu, D., Hussaarts, L., Romaine, A., Zhao, H., Fossati-Jimack, L., Malik, T., Cook, H. T., Botto, M., Lau, Y.-L., Smits, H. H., Liew, F. Y., Huang, F.-P. (2014) IL-10-producing regulatory B cells induced by IL-33 (Breg(IL-33)) effectively attenuate mucosal inflammatory responses in the gut. J. Autoimmun. 50, 107–122.
49. Turnquist, H. R., Zhao, Z., Rosborough, B. R., Liu, Q., Castellaneta, A., Isse, K., Wang, Z., Lang, M., Stolz, D. B., Zheng, X. X., Demetris, A. J., Liew, F. Y., Wood, K. J., Thomson, A. W. (2011) IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival. J. Immunol. 187, 4598–4610.
50. Matta, B. M., Lott, J. M., Mathews, L. R., Liu, Q., Rosborough, B. R., Blazar, B. R., Turnquist, H. R. (2014) IL-33 is an unconventional alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells. J. Immunol. 193, 4010–4020.
51. Schiering, C., Krausgruber, T., Chomka, A., Fröhlich, A., Adelmann, K., Wohlfert, E. A., Pott, J., Griseri, T., Bollrath, J., Hegazy, A. N., Harrison, O. J., Owens, B. M. J., Löhning, M., Belkaid, Y., Fallon, P. G., Powrie, F. (2014) The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513, 564–568.
52. Brunner, S. M., Schiechl, G., Falk, W., Schlitt, H. J., Geissler, E. K., Fichtner-Feigl, S. (2011) Interleukin-33 prolongs allograft survival during chronic cardiac rejection. Transpl. Int. 24, 1027–1039.
53. Kaplan, M. H., Schindler, U., Smiley, S. T., Grusby, M. J. (1996) Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4, 313–319.
54. Chapoval, S., Dasgupta, P., Dorsey, N. J., Keegan, A. D. (2010) Regulation of the T helper cell type 2 (Th2)/T regulatory cell (Treg) balance by IL-4 and STAT6. J. Leukoc. Biol. 87, 1011–1018.
55. Zheng, W., Flavell, R. A. (1997) The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587–596.
56. Pai, S.-Y., Truitt, M. L., Ho, I.-C. (2004) GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc. Natl. Acad. Sci. USA 101, 1993–1998.
57. Zhu, J., Min, B., Hu-Li, J., Watson, C. J., Grinberg, A., Wang, Q., Killeen, N., Urban, Jr., J. F., Guo, L., Paul, W. E. (2004) Conditional deletion of GATA3 shows its essential function in T(H)1-T(H)2 responses. Nat. Immunol. 5, 1157–1165.
58. Wang, Y., Su, M. A., Wan, Y. Y. (2011) An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 35, 337–348.
59. Guo, L., Wei, G., Zhu, J., Liao, W., Leonard, W. J., Zhao, K., Paul, W. (2009) IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc. Natl. Acad. Sci. USA 106, 13463–13468.
60. Chackerian, A. A., Oldham, E. R., Murphy, E. E., Schmitz, J., Pflanz, S., Kastelein, R. A. (2007) IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J. Immunol. 179, 2551–2555.
61. Chow, J. Y., Wong, C. K., Cheung, P. F., Lam, C. W. (2010) Intracellular signaling mechanisms regulating the activation of human eosinophils by the novel Th2 cytokine IL-33: implications for allergic inflammation. Cell. Mol. Immunol. 7, 26–34.
62. Ali, S., Huber, M., Kollewe, C., Bischoff, S. C., Falk, W., Martin, M. U. (2007) IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc. Natl. Acad. Sci. USA 104, 18660–18665.
63. Kurowska-Stolarska, M., Kewin, P., Murphy, G., Russo, R. C., Stolarski, B., Garcia, C. C., Komai-Koma, M., Pitman, N., Li, Y., Niedbala, W., McKenzie, A. N., Teixeira, M. M., Liew, F. Y., Xu, D. (2008) IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J. Immunol. 181, 4780–4790.
64. Komai-Koma, M., Xu, D., Li, Y., McKenzie, A. N. J., McInnes, I. B., Liew, F. Y. (2007) IL-33 is a chemoattractant for human Th2 cells. Eur. J. Immunol. 37, 2779–2786.
65. Pulendran, B., Artis, D. (2012) New paradigms in type 2 immunity. Science 337, 431–435.
66. Price, A. E., Liang, H.-E., Sullivan, B. M., Reinhardt, R. L., Eisley, C. J., Erle, D. J., Locksley, R. M. (2010) Systemically dispersed innate IL-13- expressing cells in type 2 immunity. Proc. Natl. Acad. Sci. USA 107, 11489–11494.
67. Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., Furusawa, J., Ohtani, M., Fujii, H., Koyasu, S. (2010) Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca- 1(+) lymphoid cells. Nature 463, 540–544.
68. Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K. A., Bucks, C., Kane, C. M., Fallon, P. G., Pannell, R., Jolin, H. E., McKenzie, A. N. J. (2010) Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464, 1367–1370.
69. McKenzie, A. N., Spits, H., Eberl, G. (2014) Innate lymphoid cells in inflammation and immunity. Immunity 41, 366–374.
70. Pulendran, B., Tang, H., Manicassamy, S. (2010) Programming dendritic cells to induce T(H)2 and tolerogenic responses. Nat. Immunol. 11, 647–655.
71. Rank, M. A., Kobayashi, T., Kozaki, H., Bartemes, K. R., Squillace, D. L., Kita, H. (2009) IL-33-activated dendritic cells induce an atypical TH2- type response. J. Allergy Clin. Immunol. 123, 1047–1054.
72. Turnquist, H. R., Sumpter, T. L., Tsung, A., Zahorchak, A. F., Nakao, A., Nau, G. J., Liew, F. Y., Geller, D. A., Thomson, A. W. (2008) IL-1betadriven ST2L expression promotes maturation resistance in rapamycinconditioned dendritic cells. J. Immunol. 181, 62–72.
73. Turnquist, H. R., Cardinal, J., Macedo, C., Rosborough, B. R., Sumpter, T. L., Geller, D. A., Metes, D., Thomson, A. W. (2010) mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS. Blood 115, 4758–4769.
74. Besnard, A.-G., Togbe, D., Guillou, N., Erard, F., Quesniaux, V., Ryffel, B. (2011) IL-33-activated dendritic cells are critical for allergic airway inflammation. Eur. J. Immunol. 41, 1675–1686.
75. Gudbjartsson, D. F., Bjornsdottir, U. S., Halapi, E., Helgadottir, A., Sulem, P., Jonsdottir, G. M., Thorleifsson, G., Helgadottir, H., Steinthorsdottir, V., Stefansson, H., Williams, C., Hui, J., Beilby, J., Warrington, N. M., James, A., Palmer, L. J., Koppelman, G. H., Heinzmann, A., Krueger, M., Boezen, H. M., Wheatley, A., Altmuller, J., Shin, H. D., Uh, S.-T., Cheong, H. S., Jonsdottir, B., Gislason, D., Park, C.-S., Rasmussen, L. M., Porsbjerg, C., Hansen, J. W., Backer, V., Werge, T., Janson, C., Jönsson, U.-B., Ng, M. C. Y., Chan, J., So, W. Y., Ma, R., Shah, S. H., Granger, C. B., Quyyumi, A. A., Levey, A. I., Vaccarino, V., Reilly, M. P., Rader, D. J., Williams, M. J. A., van Rij, A. M., Jones, G. T., Trabetti, E., Malerba, G., Pignatti, P. F., Boner, A., Pescollderungg, L., Girelli, D., Olivieri, O., Martinelli, N., Ludviksson, B. R., Ludviksdottir, D., Eyjolfsson, G. I., Arnar, D., Thorgeirsson, G., Deichmann, K., Thompson, P. J., Wjst, M., Hall, I. P., Postma, D. S., Gislason, T., Gulcher, J., Kong, A., Jonsdottir, I., Thorsteinsdottir, U., Stefansson, K. (2009) Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat. Genet. 41, 342–347.
76. Moffatt, M. F., Gut, I. G., Demenais, F., Strachan, D. P., Bouzigon, E., Heath, S., von Mutius, E., Farrall, M., Lathrop, M., Cookson, W. O. C. M.; GABRIEL Consortium. (2010) A large-scale, consortiumbased genomewide association study of asthma. N. Engl. J. Med. 363, 1211–1221.
77. Préfontaine, D., Nadigel, J., Chouiali, F., Audusseau, S., Semlali, A., Chakir, J., Martin, J. G., Hamid, Q. (2010) Increased IL-33 expression by epithelial cells in bronchial asthma. J. Allergy Clin. Immunol. 125, 752–754.
78. Kurokawa, M., Matsukura, S., Kawaguchi, M., Ieki, K., Suzuki, S., Odaka, M., Watanabe, S., Homma, T., Sato, M., Yamaguchi, M., Takeuchi, H., Adachi, M. (2011) Expression and effects of IL-33 and ST2 in allergic bronchial asthma: IL-33 induces eotaxin production in lung fibroblasts. Int. Arch. Allergy Immunol. 155 (Suppl 1), 12–20.
79. Chu, D. K., Llop-Guevara, A., Walker, T. D., Flader, K., Goncharova, S., Boudreau, J. E., Moore, C. L., In, T. S., Waserman, S., Coyle, A. J., Kolbeck, R., Humbles, A. A., Jordana, M. (2013) IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization. J. Allergy Clin. Immunol. 131, 187–200.e1–8.
80. Su, Z., Lin, J., Lu, F., Zhang, X., Zhang, L., Gandhi, N. B., de Paiva, C. S., Pflugfelder, S. C., Li, D. Q. (2013) Potential autocrine regulation of interleukin-33/ST2 signaling of dendritic cells in allergic inflammation. Mucosal Immunol. 6, 921–930.
81. Tjota, M. Y., Hrusch, C. L., Blaine, K. M., Williams, J. W., Barrett, N. A., Sperling, A. I. (2014) Signaling through FcRg-associated receptors on dendritic cells drives IL-33–dependent TH2-type responses. J. Allergy Clin. Immunol. 134, 706–713.e8.
82. Ginhoux, F., Jung, S. (2014) Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat. Rev. Immunol. 14, 392–404.
83. Anthony, R. M., Urban, Jr., J. F., Alem, F., Hamed, H. A., Rozo, C. T., Boucher, J.-L., Van Rooijen, N., Gause, W. C. (2006) Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites. Nat. Med. 12, 955–960.
84. Zhao, A., Urban Jr, J. F., Anthony, R. M., Sun, R., Stiltz, J., van Rooijen, N., Wynn, T. A., Gause, W. C., Shea-Donohue, T. (2008) Th2 cytokine-induced alterations in intestinal smooth muscle function depend on alternatively activated macrophages. Gastroenterology 135, 217–225.e1.
85. Biswas, S. K., Mantovani, A. (2010) Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11, 889–896.
86. Espinassous, Q., Garcia-de-Paco, E., Garcia-Verdugo, I., Synguelakis, M., von Aulock, S., Sallenave, J. M., McKenzie, A. N., Kanellopoulos, J. (2009) IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex. J. Immunol. 183, 1446–1455.
87. Kurowska-Stolarska, M., Stolarski, B., Kewin, P., Murphy, G., Corrigan, C. J., Ying, S., Pitman, N., Mirchandani, A., Rana, B., van Rooijen, N., Shepherd, M., McSharry, C., McInnes, I. B., Xu, D., Liew, F. Y. (2009) IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J. Immunol. 183, 6469–6477.
88. Li, D., Guabiraba, R., Besnard, A.-G., Komai-Koma, M., Jabir, M. S., Zhang, L., Graham, G. J., Kurowska-Stolarska, M., Liew, F. Y., McSharry, C., Xu, D. (2014) IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice. J. Allergy Clin. Immunol. 134, 1422–1432, e11.
89. Jiang, H. R., Milovanović, M., Allan, D., Niedbala, W., Besnard, A. G., Fukada, S. Y., Alves-Filho, J. C., Togbe, D., Goodyear, C. S., Linington, C., Xu, D., Lukic, M. L., Liew, F. Y. (2012) IL-33 attenuates EAE by suppressing IL-17 and IFN-g production and inducing alternatively activated macrophages. Eur. J. Immunol. 42, 1804–1814.
90. Nelson, M. P., Christmann, B. S., Werner, J. L., Metz, A. E., Trevor, J. L., Lowell, C. A., Steele, C. (2011) IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina. J. Immunol. 186, 2372–2381.
91. Fock, V., Mairhofer, M., Otti, G. R., Hiden, U., Spittler, A., Zeisler, H., Fiala, C., Knöfler, M., Pollheimer, J. (2013) Macrophage-derived IL-33 is a critical factor for placental growth. J. Immunol. 191, 3734–3743.
92. Granne, I., Southcombe, J. H., Snider, J. V., Tannetta, D. S., Child, T., Redman, C. W., Sargent, I. L. (2011) ST2 and IL-33 in pregnancy and pre-eclampsia. PLoS ONE 6, e24463.
93. Galli, S. J., Grimbaldeston, M., Tsai, M. (2008) Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat. Rev. Immunol. 8, 478–486.
94. Galli, S. J., Tsai, M. (2012) IgE and mast cells in allergic disease. Nat. Med. 18, 693–704.
95. Suto, H., Nakae, S., Kakurai, M., Sedgwick, J. D., Tsai, M., Galli, S. J. (2006) Mast cell-associated TNF promotes dendritic cell migration. J. Immunol. 176, 4102–4112.
96. Guermonprez, P., Helft, J., Claser, C., Deroubaix, S., Karanje, H., Gazumyan, A., Darasse-Jèze, G., Telerman, S. B., Breton, G., Schreiber, H. A., Frias-Staheli, N., Billerbeck, E., Dorner, M., Rice, C. M., Ploss, A., Klein, F., Swiecki, M., Colonna, M., Kamphorst, A. O., Meredith, M., Niec, R., Takacs, C., Mikhail, F., Hari, A., Bosque, D., Eisenreich, T., Merad, M., Shi, Y., Ginhoux, F., Rénia, L., Urban, B. C., Nussenzweig, M. C. (2013) Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection. Nat. Med. 19, 730–738.
97. Roediger, B., Kyle, R., Yip, K. H., Sumaria, N., Guy, T. V., Kim, B. S., Mitchell, A. J., Tay, S. S., Jain, R., Forbes-Blom, E., Chen, X., Tong, P. L., Bolton, H. A., Artis, D., Paul, W. E., Fazekas de St Groth, B., Grimbaldeston, M. A., Le Gros, G., Weninger, W. (2013) Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells. Nat. Immunol. 14, 564–573.
98. Xue, L., Salimi, M., Panse, I., Mjösberg, J. M., McKenzie, A. N., Spits, H., Klenerman, P., Ogg, G. (2014) Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. J. Allergy Clin. Immunol. 133, 1184–1194.
99. Mutalithas, K., Guillen, C., Day, C., Brightling, C. E., Pavord, I. D., Wardlaw, A. J. (2010) CRTH2 expression on T cells in asthma. Clin. Exp. Immunol. 161, 34–40.
100. Kawakami, T., Galli, S. J. (2002) Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol. 2, 773–786.
101. Biedermann, T., Kneilling, M., Mailhammer, R., Maier, K., Sander, C. A., Kollias, G., Kunkel, S. L., Hültner, L., Röcken, M. (2000) Mast cells control neutrophil recruitment during T cell-mediated delayedtype hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med. 192, 1441–1452.
102. Hsu, C. L., Bryce, P. J. (2012) Inducible IL-33 expression by mast cells is regulated by a calcium-dependent pathway. J. Immunol. 189, 3421–3429.
103. Tung, H. Y., Plunkett, B., Huang, S. K., Zhou, Y. (2014) Murine mast cells secrete and respond to interleukin-33. J. Interferon Cytokine Res. 34, 141–147.
104. Ho, L. H., Ohno, T., Oboki, K., Kajiwara, N., Suto, H., Iikura, M., Okayama, Y., Akira, S., Saito, H., Galli, S. J., Nakae, S. (2007) IL-33 induces IL-13 production by mouse mast cells independently of IgEFcepsilonRI signals. J. Leukoc. Biol. 82, 1481–1490.
105. Silver, M. R., Margulis, A., Wood, N., Goldman, S. J., Kasaian, M., Chaudhary, D. (2010) IL-33 synergizes with IgE-dependent and IgEindependent agents to promote mast cell and basophil activation. Inflamm. Res. 59, 207–218.
106. Iikura, M., Suto, H., Kajiwara, N., Oboki, K., Ohno, T., Okayama, Y., Saito, H., Galli, S. J., Nakae, S. (2007) IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab. Invest. 87, 971–978.
107. Drube, S., Heink, S., Walter, S., Löhn, T., Grusser, M., Gerbaulet, A., Berod, L., Schons, J., Dudeck, A., Freitag, J., Grotha, S., Reich, D., Rudeschko, O., Norgauer, J., Hartmann, K., Roers, A., Kamradt, T. (2010) The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells. Blood 115, 3899–3906.
108. Heger, K., Fierens, K., Vahl, J. C., Aszodi, A., Peschke, K., Schenten, D., Hammad, H., Beyaert, R., Saur, D., van Loo, G., Roers, A., Lambrecht, B. N., Kool, M., Schmidt-Supprian, M. (2014) A20-deficient mast cells exacerbate inflammatory responses in vivo. PLoS Biol. 12, e1001762.
109. Blom, L., Poulsen, B. C., Jensen, B. M., Hansen, A., Poulsen, L. K. (2011) IL-33 induces IL-9 production in human CD4+ T cells and basophils. PLoS ONE 6, e21695.
110. Kamijo, S., Takeda, H., Tokura, T., Suzuki, M., Inui, K., Hara, M., Matsuda, H., Matsuda, A., Oboki, K., Ohno, T., Saito, H., Nakae, S., Sudo, K., Suto, H., Ichikawa, S., Ogawa, H., Okumura, K., Takai, T. (2013) IL-33-mediated innate response and adaptive immune cells contribute to maximum responses of protease allergen-induced allergic airway inflammation. J. Immunol. 190, 4489–4499.
111. Junttila, I. S., Watson, C., Kummola, L., Chen, X., Hu-Li, J., Guo, L., Yagi, R., Paul, W. E. (2013) Efficient cytokine-induced IL-13 production by mast cells requires both IL-33 and IL-3. J. Allergy Clin. Immunol. 132, 704–712.e10.
112. Cho, K. A., Suh, J. W., Sohn, J. H., Park, J. W., Lee, H., Kang, J. L., Woo, S. Y., Cho, Y. J. (2012) IL-33 induces Th17-mediated airway inflammation via mast cells in ovalbumin-challenged mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 302, L429–L440.
113. Wang, J. X., Kaieda, S., Ameri, S., Fishgal, N., Dwyer, D., Dellinger, A., Kepley, C. L., Gurish, M. F., Nigrovic, P. A. (2014) IL-33/ST2 axis promotes mast cell survival via BCLXL. Proc. Natl. Acad. Sci. USA 111, 10281–10286.
114. Imai, Y., Yasuda, K., Sakaguchi, Y., Haneda, T., Mizutani, H., Yoshimoto, T., Nakanishi, K., Yamanishi, K. (2013) Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice. Proc. Natl. Acad. Sci. USA 110, 13921–13926.
115. Lefrançais, E., Duval, A., Mirey, E., Roga, S., Espinosa, E., Cayrol, C., Girard, J. P. (2014) Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells. Proc. Natl. Acad. Sci. USA 111, 15502–15507.
116. Roy, A., Ganesh, G., Sippola, H., Bolin, S., Sawesi, O., Dagälv, A., Schlenner, S. M., Feyerabend, T., Rodewald, H. R., Kjellén, L., Hellman, L., Åbrink, M. (2014) Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation. J. Biol. Chem. 289, 237–250.
117. Waern, I., Lundequist, A., Pejler, G., Wernersson, S. (2013) Mast cell chymase modulates IL-33 levels and controls allergic sensitization in dust-mite induced airway inflammation. Mucosal Immunol. 6, 911–920.
118. Jung, M. Y., Smrˇz, D., Desai, A., Bandara, G., Ito, T., Iwaki, S., Kang, J. H., Andrade, M. V., Hilderbrand, S. C., Brown, J. M., Beaven, M. A., Metcalfe, D. D., Gilfillan, A. M. (2013) IL-33 induces a hyporesponsive phenotype in human and mouse mast cells. J. Immunol. 190, 531–538.
119. Sandig, H., Jobbings, C. E., Roldan, N. G., Whittingham-Dowd, J. K., Orinska, Z., Takeuchi, O., Akira, S., Bulfone-Paus, S. (2013) IL-33 causes selective mast cell tolerance to bacterial cell wall products by inducing IRAK1 degradation. Eur. J. Immunol. 43, 979–988.
120. Rosenberg, H. F., Dyer, K. D., Foster, P. S. (2013) Eosinophils: changing perspectives in health and disease. Nat. Rev. Immunol. 13, 9–22.
121. Molofsky, A. B., Nussbaum, J. C., Liang, H. E., Van Dyken, S. J., Cheng, L. E., Mohapatra, A., Chawla, A., Locksley, R. M. (2013) Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J. Exp. Med. 210, 535–549.
122. Rothenberg, M. E., Hogan, S. P. (2006) The eosinophil. Annu. Rev. Immunol. 24, 147–174.
123. Cherry, W. B., Yoon, J., Bartemes, K. R., Iijima, K., Kita, H. (2008) A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J. Allergy Clin. Immunol. 121, 1484–1490.
124. Bouffi, C., Rochman, M., Zust, C. B., Stucke, E. M., Kartashov, A., Fulkerson, P. C., Barski, A., Rothenberg, M. E. (2013) IL-33 markedly activates murine eosinophils by an NF-kB-dependent mechanism differentially dependent upon an IL-4-driven autoinflammatory loop. J. Immunol. 191, 4317–4325.
125. Hung, L. Y., Lewkowich, I. P., Dawson, L. A., Downey, J., Yang, Y., Smith, D. E., Herbert, D. R. (2013) IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms. Proc. Natl. Acad. Sci. USA 110, 282–287.
126. Haenuki, Y., Matsushita, K., Futatsugi-Yumikura, S., Ishii, K. J., Kawagoe, T., Imoto, Y., Fujieda, S., Yasuda, M., Hisa, Y., Akira, S., Nakanishi, K., Yoshimoto, T. (2012) A critical role of IL-33 in experimental allergic rhinitis. J. Allergy Clin. Immunol. 130, 184–194.e11.
127. Savinko, T., Karisola, P., Lehtimäki, S., Lappetel äinen, A. M., Haapakoski, R., Wolff, H., Lauerma, A., Alenius, H. (2013) ST2 regulates allergic airway inflammation and T-cell polarization in epicutaneously sensitized mice. J. Invest. Dermatol. 133, 2522–2529.
128. Gorski, S. A., Hahn, Y. S., Braciale, T. J. (2013) Group 2 innate lymphoid cell production of IL-5 is regulated by NKT cells during influenza virus infection. PLoS Pathog. 9, e1003615.
129. Yasuda, K., Muto, T., Kawagoe, T., Matsumoto, M., Sasaki, Y., Matsushita, K., Taki, Y., Futatsugi-Yumikura, S., Tsutsui, H., Ishii, K. J., Yoshimoto, T., Akira, S., Nakanishi, K. (2012) Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematodeinfected mice. Proc. Natl. Acad. Sci. USA 109, 3451–3456.
130. Sullivan, B. M., Locksley, R. M. (2009) Basophils: a nonredundant contributor to host immunity. Immunity 30, 12–20.
131. Motomura, Y., Morita, H., Moro, K., Nakae, S., Artis, D., Endo, T. A., Kuroki, Y., Ohara, O., Koyasu, S., Kubo, M. (2014) Basophil-derived interleukin-4 controls the function of natural helper cells, a member of ILC2s, in lung inflammation. Immunity 40, 758–771.
132. Tang, H., Cao, W., Kasturi, S. P., Ravindran, R., Nakaya, H. I., Kundu, K., Murthy, N., Kepler, T. B., Malissen, B., Pulendran, B. (2010) The T helper type 2 response to cysteine proteases requires dendritic cellbasophil cooperation via ROS-mediated signaling. Nat. Immunol. 11, 608–617.
133. Sokol, C. L., Chu, N. Q., Yu, S., Nish, S. A., Laufer, T. M., Medzhitov, R. (2009) Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat. Immunol. 10, 713–720.
134. Hammad, H., Plantinga, M., Deswarte, K., Pouliot, P., Willart, M. A., Kool, M., Muskens, F., Lambrecht, B. N. (2010) Inflammatory dendritic cells—not basophils—are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen. J. Exp. Med. 207, 2097–2111.
135. Schneider, E., Petit-Bertron, A. F., Bricard, R., Levasseur, M., Ramadan, A., Girard, J. P., Herbelin, A., Dy, M. (2009) IL-33 activates unprimed murine basophils directly in vitro and induces their in vivo expansion indirectly by promoting hematopoietic growth factor production. J. Immunol. 183, 3591–3597.
136. Rivellese, F., Suurmond, J., de Paulis, A., Marone, G., Huizinga, T. W., Toes, R. E. (2014) IgE and IL-33-mediated triggering of human basophils inhibits TLR4-induced monocyte activation. Eur. J. Immunol. 44, 3045–3055.
137. Suzukawa, M., Iikura, M., Koketsu, R., Nagase, H., Tamura, C., Komiya, A., Nakae, S., Matsushima, K., Ohta, K., Yamamoto, K., Yamaguchi, M. (2008) An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J. Immunol. 181, 5981–5989.
138. Kroeger, K. M., Sullivan, B. M., Locksley, R. M. (2009) IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38alphadependent pathway. J. Leukoc. Biol. 86, 769–778.
139. Enoksson, M., Möller-Westerberg, C., Wicher, G., Fallon, P. G., Forsberg-Nilsson, K., Lunderius-Andersson, C., Nilsson, G. (2013) Intraperitoneal influx of neutrophils in response to IL-33 is mast celldependent. Blood 121, 530–536.
140. Lefrançais, E., Roga, S., Gautier, V., Gonzalez-de-Peredo, A., Monsarrat, B., Girard, J.-P., Cayrol, C. (2012) IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc. Natl. Acad. Sci. USA 109, 1673–1678.
141. Walker, J. A., Barlow, J. L., McKenzie, A. N. (2013) Innate lymphoid cells—how did we miss them? Nat. Rev. Immunol. 13, 75–87.
142. Mirchandani, A. S., Besnard, A. G., Yip, E., Scott, C., Bain, C. C., Cerovic, V., Salmond, R. J., Liew, F. Y. (2014) Type 2 innate lymphoid cells drive CD4+ Th2 cell responses. J. Immunol. 192, 2442–2448.
143. Oliphant, C. J., Hwang, Y. Y., Walker, J. A., Salimi, M., Wong, S. H., Brewer, J. M., Englezakis, A., Barlow, J. L., Hams, E., Scanlon, S. T., Ogg, G. S., Fallon, P. G., McKenzie, A. N. (2014) MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity 41, 283–295.
144. Drake, L. Y., Iijima, K., Kita, H. (2014) Group 2 innate lymphoid cells and CD4+ T cells cooperate to mediate type 2 immune response in mice. Allergy 69, 1300–1307.
145. Salimi, M., Barlow, J. L., Saunders, S. P., Xue, L., Gutowska-Owsiak, D., Wang, X., Huang, L.-C., Johnson, D., Scanlon, S. T., McKenzie, A. N. J., Fallon, P. G., Ogg, G. S. (2013) A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J. Exp. Med. 210, 2939–2950.
146. Kim, B. S., Siracusa, M. C., Saenz, S. A., Noti, M., Monticelli, L. A., Sonnenberg, G. F., Hepworth, M. R., Van Voorhees, A. S., Comeau, M. R., Artis, D. (2013) TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci. Transl. Med. 5, 170-16.
147. Barlow, J. L., Bellosi, A., Hardman, C. S., Drynan, L. F., Wong, S. H., Cruickshank, J. P., McKenzie, A. N. (2012) Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J. Allergy Clin. Immunol. 129, 191–198.e1–4.
148. Halim, T. Y., Krauss, R. H., Sun, A. C., Takei, F. (2012) Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 36, 451–463.
149. Halim, T. Y., Steer, C. A., Mathä, L., Gold, M. J., Martinez-Gonzalez, I., McNagny, K. M., McKenzie, A. N., Takei, F. (2014) Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cellmediated allergic lung inflammation. Immunity 40, 425–435.
150. Chang, Y.-J., Kim, H. Y., Albacker, L. A., Baumgarth, N., McKenzie, A. N. J., Smith, D. E., Dekruyff, R. H., Umetsu, D. T. (2011) Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. 12, 631–638.
151. Wong, S. H., Walker, J. A., Jolin, H. E., Drynan, L. F., Hams, E., Camelo, A., Barlow, J. L., Neill, D. R., Panova, V., Koch, U., Radtke, F., Hardman, C. S., Hwang, Y. Y., Fallon, P. G., McKenzie, A. N. J. (2012) Transcription factor RORa is critical for nuocyte development. Nat. Immunol. 13, 229–236.
152. Hoyler, T., Klose, C. S., Souabni, A., Turqueti-Neves, A., Pfeifer, D., Rawlins, E. L., Voehringer, D., Busslinger, M., Diefenbach, A. (2012) The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37, 634–648.
153. McHedlidze, T., Waldner, M., Zopf, S., Walker, J., Rankin, A. L., Schuchmann, M., Voehringer, D., McKenzie, A. N., Neurath, M. F., Pflanz, S., Wirtz, S. (2013) Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity 39, 357–371.
154. Henderson, N. C., Iredale, J. P. (2007) Liver fibrosis: cellular mechanisms of progression and resolution. Clin. Sci. 112, 265–280.
155. Holt, A. P., Salmon, M., Buckley, C. D., Adams, D. H. (2008) Immune interactions in hepatic fibrosis. Clin. Liver Dis. 12, 861–882, x.
156. Wynn, T. A. (2008) Cellular and molecular mechanisms of fibrosis. J. Pathol. 214, 199–210.
157. Nishida, A., Andoh, A., Imaeda, H., Inatomi, O., Shiomi, H., Fujiyama, Y. (2010) Expression of interleukin 1-like cytokine interleukin 33 and its receptor complex (ST2L and IL1RAcP) in human pancreatic myofibroblasts. Gut 59, 531–541.
158. Xiangyang, Z., Lutian, Y., Lin, Z., Liping, X., Hui, S., Jing, L. (2012) Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis. Cytokine 58, 6–9.
159. Luzina, I. G., Kopach, P., Lockatell, V., Kang, P. H., Nagarsekar, A., Burke, A. P., Hasday, J. D., Todd, N. W., Atamas, S. P. (2013) Interleukin-33 potentiates bleomycin-induced lung injury. Am. J. Respir. Cell Mol. Biol. 49, 999–1008.
160. Li, J., Razumilava, N., Gores, G. J., Walters, S., Mizuochi, T., Mourya, R., Bessho, K., Wang, Y. H., Glaser, S. S., Shivakumar, P., Bezerra, J. A. (2014) Biliary repair and carcinogenesis are mediated by IL-33- dependent cholangiocyte proliferation. J. Clin. Invest. 124, 3241–3251.
161. Turner, J.-E., Morrison, P. J., Wilhelm, C., Wilson, M., Ahlfors, H., Renauld, J.-C., Panzer, U., Helmby, H., Stockinger, B. (2013) IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminthinduced lung inflammation. J. Exp. Med. 210, 2951–2965.
162. Berasain, C., Avila, M. A. (2014) Amphiregulin. Semin. Cell Dev. Biol. 28, 31–41.
163. Yin, H., Li, X., Hu, S., Liu, T., Yuan, B., Ni, Q., Lan, F., Luo, X., Gu, H., Zheng, F. (2013) IL-33 promotes Staphylococcus aureus-infected wound healing in mice. Int. Immunopharmacol. 17, 432–438.
164. Salmond, R. J., Mirchandani, A. S., Besnard, A.-G., Bain, C. C., Thomson, N. C., Liew, F. Y. (2012) IL-33 induces innate lymphoid cell–mediated airway inflammation by activating mammalian target of rapamycin. J. Allergy Clin. Immunol. 130, 1159–1166.e6.
165. De Boever, E. H., Ashman, C., Cahn, A. P., Locantore, N. W., Overend, P., Pouliquen, I. J., Serone, A. P., Wright, T. J., Jenkins, M. M., Panesar, I. S., Thiagarajah, S. S., Wenzel, S. E. (2014) Efficacy and safety of an anti-IL-13 mAb in patients with severe asthma: a randomized trial. J. Allergy Clin. Immunol. 133, 989–996.